Priorities for Endometriosis Research: A Proposed Focus on Deep Dyspareunia

review OA: closed CC0 ⤵ 68 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-06

This paper proposes a multidisciplinary research focus on deep dyspareunia in endometriosis, addressing its complex visceral, hypersensitivity, and psychological components beyond simple biometric assessment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-06 · read from full text

This paper proposes research priorities for endometriosis, centering on deep dyspareunia, using a high-level synthesis of existing evidence and conceptual models of endometriosis-related pain. It argues that deep dyspareunia reflects not only chronic inflammation–related nociception but also hyperalgesia, altered cortical perception, and psychological contributors, meaning a purely biometric assessment cannot capture impacts on sexual function, psychological well-being, body-image/self-esteem, and relational adjustment. A key limitation explicitly implied is that the work is a consensus/recommendations piece rather than new experimental data, so it does not provide original prevalence estimates or causal testing. Relevance to endometriosis: deep dyspareunia is presented as a major symptom with increased risk in women with endometriosis and as a focus for future endometriosis research within an international consensus framework, even though adenomyosis is not discussed.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 10,341 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Women with endometriosis have a substantial increase in risk of deep dyspareunia with respect to the general female population of corresponding age. This symptom has personal and intimate implications, including unfavorable emotional impact in partners. Deep dyspareunia caused by endometriosis can be viewed as an originally visceral type of pain secondary to chronic inflammation (nociception) but with several superimposed components, including hyperalgesia, abnormal cortical perception, and psychological factors. Therefore, a simplistic biometric approach does not allow a comprehensive and elaborated assessment of the global impact of the symptom on women’s sexual function, psychological well-being, body-image, self-esteem, and relational adjustment. We suggest 10 specific issues to be addressed in future research on a clinically as well as scientifically neglected aspect of female health. Time has come to address this physically and psychologically distressing affliction without embarrassment and with a decidedly multidisciplinary perspective. Similar content being viewed by others

References

Vercellini P. Endometriosis: what a pain it is. Semin Reprod Endocrinol. 1997;15:251–261. Vercellini P, Viganò P, Somigliana E, Abbiati A, Barbara G, Fedele L. Chronic pelvic pain in women: etiology, pathogenesis and diagnostic approach. Gynecol Endocrinol. 2009;25(3):149–158. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study-Part 1. BJOG. 2008;115(1):1382–1391. Ferrero S, Ragni N, Remorgida V. Deep dyspareunia: causes, treatments, and results. Curr Opin Obstet Gynecol. 2008;20(4):394–399. Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. Fertil Steril. 2006;86(6):1561–1572. Simoens S, Hummelshoj L, D’Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update. 2007;13(4):395–404. Meana M, Cho R, DesMeules M. Chronic pain: the extra burden on Canadian women. BMC Womens Health. 2004;4(suppl 1):S17. Biberoglu KO, Behrman SJ. Dosage spects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol. 1981;139(6):645–654. Vercellini P, Pietropaolo G, De Giorgi O, Pasin R, Chiodini A, Crosignani PG. Treatment of symptomatic rectovaginal endometriosis with an estrogen- progestogen combination versus low-dose norethindrone acetate. Fertil Steril. 2005;84(5):1375–1387. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60(1):75–79. Meana M, Binik YM. Dyspareunia: causes and treatments. In: Vercellini P, ed. Gynecology in Practice. Chronic Pelvic Pain. Oxford, UK: John Wiley & Sons; 2010. In press. Fernandez I, Reid C, Dziurawiec S. Living with endometriosis: the perspective of male partners. J Psychosom Res. 2006;61(4):433–438. Ferrero S, Esposito F, Abbamonte LH, Anserini P, Remorgida V, Ragni N. Quality of sex life in women with endometriosis and deep dyspareunia. Fertil Steril. 2005;83(3):573–579. Meana M, Lykins A. Negative affect and somatically focused anxiety in young women reporting pain with intercourse. J Sex Res. 2009;46(1):80–88. Vercellini P, Bocciolone L, Vendola N, Colombo A, Rognoni MT, Fedele L. Peritoneal endometriosis. Morphologic appearance in women with chronic pelvic pain. J Reprod Med. 1991;36(7):533–536. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril. 1996;65(2):299–304. Fauconnier A, Chapron C, Dubuisson JB, Vieira M, Dousset B, Breart G. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril. 2002;78(4):719–726. Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005;11(6):595–606. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis on 1000 patients. Hum Reprod. 2007;22(1):266–271. Anaf V, Simon P, El Nakadi I, et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod. 2002;17(7):1895–1900. Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol. 2009;16(5):540–550. Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noel JC. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril. 2006;86(5):1336–1343. Anaf V, Simon P, El Nakadi I, et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod. 2000;15(8):1744–1750. Giamberardino MA, De Laurentis S, Affaitati G, Lerza R, Lapenna D, Vecchiet L. Modulation of pain and hyperalgesia from the urinary tract by algogenic conditions of the reproductive organs in women. Neurosci Lett. 2001;304(1–2):61–64. Bajaj P, Bajaj P, Madsen H, Arendt-Nielsen L. Endometriosis is associated with central sensitization: a psychophysical controlled study. J Pain. 2003;4(7):372–380. Nunnink S, Meana M. Remembering the pain: accuracy of pain recall in endometriosis. J Psychosom Obstet Gynaecol. 2007;28(4):201–208. Denny E. Women’s experience of endometriosis. J Adv Nurs. 2004;46(6):641–648. Somigliana E, Viganò P, Barbara G, Vercellini P. Treatment of endometriosis-related pain: options and outcomes. Front Biosci. 2009;1:455–465. Vercellini P, Frontino G, Pietropaolo G, Gattei U, Daguati R, Crosignani PG. Deep endometriosis: definition, pathogenesis, and clinical management. J Am Assoc Gynecol Laparosc. 2004;11(2):153–161. Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol. 2008;22(2):275–306. Vercellini P, Somigliana E, Viganò P, Abbiati A, Barbara G, Crosignani PG. Endometriosis: current therapies and new pharmacological developments. Drugs. 2009;69(6):649–675. Vercellini P, Crosignani PG, Somigliana E, Berlanda N, Barbara G, Fedele L. Medical treatment for rectovaginal endometriosis: what is the evidence?. Hum Reprod. 2009;24(10):2504–2514. Remorgida V, Abbamonte HL, Ragni N, Fulcheri E, Ferrero S. Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertil Steril. 2007;88(3):724–726. Ferrero S, Camerni G, Seracchioli R, Ragni N, Venturini PL, Remorgida V. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod. 2009;24(12):3033–3041. Ferrero S, Camerini G, Ragni N, Venturini PL, Biscaldi E, Remorgida V. Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study. Hum Reprod. 2010;25(1):94–100. Anaf V, Simon P, El Nakadi I, Simonart T, Noel JC, Buxant F. Impact of surgical resection of rectovaginal pouch of douglas endometriotic nodules on pelvic pain and some elements of patients’ sex life. J Am Assoc Gynecol Laparosc. 2001;8(1):55–60. Vercellini P, Pietropaolo G, De Giorgi O, Daguati R, Pasin R, Crosignani PG. Reproductive performance in infertile women with rectovaginal endometriosis: is surgery worthwhile?. Am J Obstet Gynecol. 2006;195(5):1303–1310. Ferrero S, Abbamonte LH, Giordano M, Ragni N, Remorgida V. Deep dyspareunia and sex life after laparoscopic excision of endometriosis. Hum Reprod. 2007;22(4):1142–1148. Vercellini P, Carmignani L, Rubino T, Barbara G, Abbiati A, Fedele L. Surgery for deep endometriosis: a pathogenesis-oriented approach. Gynecol Obstet Invest. 2009;68(2):88–103. Vercellini P, Crosignani PG, Abbiati A, Somigliana E, Viganò P, Fedele L. The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update. 2009;15(2):177–188. Rogers PAW, D’Hooghe TM, Fazleabas A, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16(4):335–346. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther. 2003;29(1):39–46. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20. Vercellini P, Fedele L, Bianchi S, Candiani GB. Pelvic denervation for chronic pain associated with endometriosis: fact or fancy?. Am J Obstet Gynecol. 1991;165(3):745–749. Hummelshoj L. Endometriosis—how big is the problem? In: Garcia-Velasco JA, Rizk BRM, eds. Endometriosis: Current Management and Future Trends. India; Jaypee Brothers Medical Publisher; 2010:3–9. Weijts W, Houtkoop H, Keller SD. Talking delicacy: speaking about sexuality during gynaecological consultations. Sociol Health Illn. 1993;15:295–314. World Health Organization. Gender and human rights. Defining sexual health. Retrieved from http://www.who.int/reproductivehealth/topics/gender_rights/defining_sexual_health/en/index.html on March 8, 2010. World Health Organization. Gender and human rights. Sexual health. Retrieved from http://www.who.int/reproductivehealth/topics/gender_rights/sexual_health/en/index.html on March 8, 2010. D’Hooghe T, Hummelshoj L. Multi-disciplinary centres/networks of excellence for endometriosis management and research: a proposal. Hum Reprod. 2006;21(11):2743–2748. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Vercellini, P., Meana, M., Hummelshoj, L. et al. Priorities for Endometriosis Research: A Proposed Focus on Deep Dyspareunia. Reprod. Sci. 18, 114–118 (2011). https://doi.org/10.1177/1933719110382921 Published: Issue date: DOI: https://doi.org/10.1177/1933719110382921

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

mesh:D004414mesh:D004715endometriosisdyspareunia

MeSH descriptors

Dyspareunia Endometriosis Health Priorities Sexuality Dyspareunia Dyspareunia Dyspareunia Endometriosis Endometriosis Endometriosis Female Humans Risk Factors Sexuality Sexuality

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (51)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:17:00.782903+00:00
License: CC0 · commercial use OK